Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias. (Q44362112)
Jump to navigation
Jump to search
scientific article published in March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias. |
scientific article published in March 2003 |
Statements
1 reference
Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias. (English)
1 reference
Hagop M Kantarjian
1 reference
Stefan Faderl
1 reference
Guillermo Garcia-Manero
1 reference
Jorge E Cortes
1 reference
Elihu H Estey
1 reference
Francis J Giles
1 reference
Sima S Jeha
1 reference
Dan Douer
1 reference
Susan M O'Brien
1 reference
Deborah A Thomas
1 reference
Alexandra M Levine
1 reference
Charles A Koller
1 reference
1 March 2003
1 reference
1 reference
21
1 reference
6
1 reference
1050-1056
1 reference
Identifiers
1 reference
1 reference